nafarelin
Selected indexed studies
- Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions. (Drugs, 1990) [PMID:2140979]
- Efficacy of nafarelin in assisted reproductive technology: a meta-analysis. (Hum Reprod Update, 2001) [PMID:11212082]
- Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature. (J Reprod Med, 2000) [PMID:10900582]
_Worker-drafted node — pending editorial review._
Connections
nafarelin is a side effect of
Sources
- Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions. (1990) pubmed
- Efficacy of nafarelin in assisted reproductive technology: a meta-analysis. (2001) pubmed
- Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature. (2000) pubmed
- Consensus statement on the use of gonadotropin-releasing hormone analogs in children. (2009) pubmed
- Nafarelin in the management of endometriosis: quality of life assessment. (1992) pubmed
- Comparison of the pharmacology of nafarelin and danazol. (1990) pubmed
- Bioavailability of nafarelin in healthy volunteers. (1992) pubmed
- Hereditary Coproporphyria. (1993) pubmed
- Cost comparisons between nafarelin and leuprolide in the treatment of endometriosis. (1998) pubmed
- Nafarelin in the treatment of endometriosis. Dose management. (1994) pubmed